Home LiteratureArticle Details
PMID: 17513574 Published · ppublish English Clinical Trial Letter

Anakinra treatment in patients with adult-onset Still's disease is fast, effective, safe and steroid sparing: experience from an uncontrolled trial.

Annals of the rheumatic diseases ·Vol. 66 ·No. 6 ·2007-06-00 ·Pages 842-3

Kalliolias GD, Georgiou PE, Antonopoulos IA, Andonopoulos AP, Liossis SN

Abstract

暂无摘要

MeSH Terms
Adolescent Adult Antirheumatic Agents/therapeutic use Drug Administration Schedule Drug Therapy, Combination Female Glucocorticoids/administration & dosage Humans Interleukin 1 Receptor Antagonist Protein/therapeutic use Male Middle Aged Still's Disease, Adult-Onset/drug therapy Treatment Outcome
Chemicals
Antirheumatic Agents Glucocorticoids Interleukin 1 Receptor Antagonist Protein
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Kalliolias George D
Georgiou Panagiotis E
Antonopoulos Ioannis A
Andonopoulos Andrew P
Liossis Stamatis-Nick C
References (7)
7 references, click to expand
  1. Tumour necrosis factor alpha blocking agents in refractory adult Still's disease: an observational study of 20 cases.
    Ann Rheum Dis. 2005 Feb;64(2):262-6 PMID: 15184196
  2. Refractory adult onset Still's disease successfully treated with anakinra.
    Ann Rheum Dis. 2005 Apr;64(4):647-8 PMID: 15374853
  3. Blocking IL-1 in systemic inflammation.
    J Exp Med. 2005 May 2;201(9):1355-9 PMID: 15867089
  4. Rapid responses to anakinra in patients with refractory adult-onset Still's disease.
    Arthritis Rheum. 2005 Jun;52(6):1794-803 PMID: 15934079
  5. Refractory adult onset Still's disease and hypersensitivity to non-steroidal anti-inflammatory drugs and cyclo-oxygenase-2 inhibitors: are biological agents the solution?
    Ann Rheum Dis. 2005 Oct;64(10):1523-4 PMID: 16014669
  6. Adult Still's disease: review of 228 cases from the literature.
    J Rheumatol. 1987 Dec;14(6):1139-46 PMID: 3325642
  7. Preliminary criteria for classification of adult Still's disease.
    J Rheumatol. 1992 Mar;19(3):424-30 PMID: 1578458
Article Info
Journal
Annals of the rheumatic diseases
Abbr.
Ann Rheum Dis
ISSN
0003-4967
DOI
10.1136/ard.2006.066381
Published
2007-06-00
Pages
842-3
Language
English
Region
England
NLM ID
0372355
PMCID
PMC1954650
Subset
IM
External Links
PubMed source DOI: 10.1136/ard.2006.066381 PMC Full Text View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2